Given that SNX5 is a negative prognostic marker for liver cancer and plays a role in promoting thyroid cancer progression by stabilizing growth factor receptors, C11orf42 may contribute to these pathological processes via its interaction with SNX5 [26, 79]. The gene discussed is SNX5; the disease is thyroid gland carcinoma.